The Anthracycline Metabolite Doxorubicinol Abolishes RyR2 Sensitivity to Physiological Changes in Luminal Ca
2+ through an Interaction with Calsequestrin.
Amy D. Hanna, Alexander Lam, Chris Thekkedam, Hermia Willemse, Angela F. Dulhunty, Nicole A. Beard
Dive into the research topics of 'The Anthracycline Metabolite Doxorubicinol Abolishes RyR2 Sensitivity to Physiological Changes in Luminal Ca 2+ through an Interaction with Calsequestrin.'. Together they form a unique fingerprint.